(IN BRIEF) A new study reveals that diabetes cost the UK nearly £14 billion in 2021/22, with over £10 billion in direct NHS costs. Complications from diabetes account for the largest share of these costs. Despite advancements in management technologies, … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged Colette Marshall, Diabetes, Diabetes UK, Financial, investment, Nick Hex, Prevention and Care, University of York, wellness
(IN BRIEF) A recent study led by the University of Exeter has identified a connection between consistently high blood sugar levels and upper limb conditions such as frozen shoulder, Dupuytren’s disease, carpal tunnel syndrome, and trigger finger. The research, conducted … Read the full press release
(IN BRIEF) IQ Biozoom, a medical technology startup, is developing non-invasive home diagnostics that allow people to measure the concentration of biochemical substances in liquid analytes like saliva, sweat, urine, or tears. Their technology integrates inkjet printing with advanced semiconductors, … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Poland, Small Business, Technology
Tagged biomarker, biosensor system, blood glucose, blood glucose meters, Diabetes, endocrine disorders, glucose, glucose monitoring, home diagnostics, home tests, IQ Biozoom, lactate levels, medical technology, medical technology startup, medtech, metabolic disorders, non-invasive home diagnostics, non-invasive home testing, personalised medicine, saliva analysis, sports medicine, startup, VC Link fund
(IN BRIEF) Novo Nordisk A/S is in exclusive negotiations to acquire a controlling stake in BIOCORP Production SA, a French company specializing in medical device design and manufacturing. The acquisition would be followed by a mandatory tender offer for all … Read the full press release
(IN BRIEF) Novo Nordisk has announced a collaboration with Aspect Biosystems to develop bioprinted tissue therapeutics for diabetes and obesity treatment. The collaboration will leverage Aspect’s bioprinting technology and Novo Nordisk’s expertise in stem cell differentiation and cell therapy development … Read the full press release
12 million litres of SAF (sustainable aviation fuel) to minimise environmental impact of Novo Nordisk air freight globally Sustainable fuel offering to support customers’ pledge for carbon-neutral shipping Advocating for more sustainable fuel production and use (PRESS RELEASE) SCHINDELLEGI, 20-Oct-2022 … Read the full press release
Posted in Business, Denmark, Energy, Gas & Oil, Environment, Healthcare, News, Switzerland, Transportation & Logistics
Tagged air freight, air freight shipments, air logistics, carbon reduction targets, Diabetes, Dorethe Nielsen, Kuehne+Nagel, Novo Nordisk, SAF, shipping, sustainable aviation fuel, Yngve Ruud
12 millones de litros de SAF (combustible de aviación sostenible) para minimizar el impacto ambiental de la carga aérea de Novo Nordisk a nivel mundial Oferta de combustible sostenible para respaldar el compromiso de los clientes de envíos sin emisiones … Read the full press release
Posted in Business, Denmark, Energy, Gas & Oil, Environment, Healthcare, Switzerland, Transportation & Logistics
Tagged carga aérea, combustible de aviación sostenible, Diabetes, Dorethe Nielsen, envíos de carga aérea, Kuehne+Nagel, logística aérea, Novo Nordisk, objetivos de reducción de carbono, SAF, transporte marítimo, Yngve Ruud
4 million1 hours of hypoglycemia avoided Trust in the algorithm leads to fewer meal declarations Users report a significantly reduced mental load (PRESS RELEASE) PARIS, 21-Sep-2022 — /EuropaWire/ — Diabeloop, a leader in therapeutic AI applied to insulin delivery, reports … Read the full press release
Posted in Denmark, France, Healthcare, News, Pharma & Biotech, Science, Sweden, Technology
Tagged #dedoc, automated insulin delivery, DBL-4pen, DBL-hu, DBLG1, Diabeloop, Diabetes, EASD, EASD Annual Meeting 2022, EASD2022, Erik Huneker, hybrid closed-loop system, Hypoglycemia, insulin delivery, Pr. Lutz Heinemann, Pr. Pierre-Yves Benhamou, Stéphanie JEGU, therapeutic AI, Time In Range, type 1 diabetes
High-growth diabetes company Diabeloop closes its Series C financing round – led by LBO France, joined by Terumo Corporation, Innovacom and backed by Diabeloop’s historical partners – to power the company’s commercial roll-out and global expansion. (PRESS RELEASE) PARIS, 2-Jun-2022 … Read the full press release
Posted in Artificial Intelligence (AI), Denmark, Financial, France, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged AGIR A DOM., AI, automated insulin delivery, Catherine Dunand, CEMAG invest, CERITD, CGM, Continuous Glucose Monitoring device, Credit Agricole, DBL-hu, DBLG1, DBLG1 System, Diabeloop, Diabetes, Erik Huneker, financing round, Hikaru Samejima, Innovacom, insulin, Kreaxi, LBO France, ML software for diabetes treatment, Odyssée Venture, Promontoires, Series C, Series C financing round, Sofimac, Stéphanie JEGU, Supernova Invest, T1D, Terumo, Terumo Corporation, therapeutic AI, therapeutic artificial intelligence, type 1 diabetes, UI Investissement, Valery Huot
(PRESS RELEASE) PARIS, 28-Apr-2022 — /EuropaWire/ — ATTD 2022 – Diabeloop, pioneer in therapeutic artificial intelligence for diabetes management, presents today new results from a real-life cohort in Germany. The data show a constant improvement in Time In Range (70-180 … Read the full press release
Posted in Artificial Intelligence (AI), Denmark, France, Healthcare, News, Pharma & Biotech, Science, Spain, Technology
Tagged Accu-Chek Insight, AI, aid, artificial-intelligence, ATTD 2022, automated insulin delivery, biphasic boluses, blood sugar level, DBL-hu, DBLG1, DBLG1 iController, DBLG1 System, Diabeloop, Diabetes, diabetes management, Erik Huneker, glucose control, glycemic control, HbA1c, Insulin Pump, postprandial hyperglycemia, Prof. Pierre-Yves Benhamou, real-life DBLG1 cohort, reduction of hypoglycemia, reduction of hypoglycemic episodes, Roche, Stéphanie JEGU, T1D, Time In Range, TIR, type 1 diabetes, WP7, WP72 study, YourLoops
(PRESS RELEASE) PARIS, 12-Apr-2022 — /EuropaWire/ — Diabeloop, a pioneer in the field of therapeutic artificial intelligence, leverages the potential of its diabetes technology to enable the integration of insulin pens into its hybrid closed-loop system using a unique app. … Read the full press release
Posted in Denmark, France, Healthcare, News, Pharma & Biotech, Spain, Technology
Tagged aid, automated insulin delivery, BIOCORP, DBL-4pen, DBL-hu, DBLG1, Diabeloop, Diabetes, Erik Huneker, insulin pen, insulin therapy, Mallya®, Marc Julien, multiple daily insulin injections, Prof. Hélène Hanaire, Seagrove Partners, Simon-Kucher, smart pen, Stéphanie JEGU, therapeutic AI, type 1 diabetes, type 2 diabetes, University Hospital of Toulouse, YourLoops
(PRESS RELEASE) EXETER, 17-Dec-2021 — /EuropaWire/ — University of Exeter, a public research university in Exeter, Devon, South West England, United Kingdom, has announced that a research that it led together with Rigel Pharmaceuticals (NASDAQ: RIGL), a biotech firm dedicated … Read the full press release
Posted in Education, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AMPK, anxiety, blood sugar levels, blood sugars, brain-pancreas, coma, confusion, Conor McKeever, Diabetes, Diabetes UK, dizziness, Dr Ana Cruz, Dr Craig Beall, Dr Lucy Chambers, Endocrinology, Frontiers in Endocrinology, glucose-sensing neurons, GT1-7 cells, hormonal defence systems, Hunger, hyperglycaemia, hypoglycaemia, hypos, insulin, JDRF, loss of consciousness, low blood sugar, metformin, palpitations, R481, RESEARCH, Rigel Pharmaceuticals, sweating, University of Exeter
EASD 2021 – Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, is presenting new real-world data(1) of its Automated Insulin Delivery system, DBLG1. The personalized device fine-tunes insulin delivery using a state-of-the-art algorithm. Thousands of European patients have … Read the full press release
Posted in Artificial Intelligence (AI), France, Healthcare, Italy, News, Pharma & Biotech, Science, Spain, Technology
Tagged ACCU-CHEK, Accu-Chek Insight, algorithm, artificial-intelligence, Automated Insulin Delivery system, CE certificate, CGM, continuous glucose monitor, data, data visualization platform, DBLG1, DBLG1 System, Dexcom, Dexcom G6, Diabeloop, Diabetes, EASD 2021, Erik Huneker, glucose, HbA1c, Hypoglycemia, Insulin Pump, Pr. Pierre-Yves Benhamou, Roche, Stéphanie JEGU, T1D, therapeutic artificial intelligence, therapeutic artificial intelligence for diabetes management, Time In Range, TÜV Rheinland, type 1 diabetes, YourLoops
(PRESS RELEASE) PARIJS, 2-Jun-2021 — /EuropaWire/ — Vanaf het begin heeft Diabeloop innovatieve systemen ontwikkeld om de behandeling van diabetes type 1 te automatiseren en te personaliseren, waarbij altijd rekening wordt gehouden met de optiek van de patiënt. Het Franse … Read the full press release
Posted in Belgium, France, Healthcare, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged algoritme, ATTD 2021, ATTD2021, Bernhard Gehr, CEA-Leti, CERITD, DBLG1, DBLG1 AID-systeem, DBLG1 System, DBLG1 System met Accu-Check Insight, DBLG1-algoritme, Diabeloop, Diabetes, diabetes type 1, diabetesbehandeling, diabetologen, diabetoloog, Dr. Guillaume Charpentier, Erik Huneker, gepersonaliseerde behandeling, insulinedosis, m&i Fachklinik Bad Heilbrunn, Marc Julien, Nicole Wetzels, Roche Diabetes Care, T1D, Yousra Tourki, zelflerend algoritme
Accelerating projects on access to medicines, support for vulnerable communities, environmental conservation, and diversity and inclusion Creation of Sanofi Global Health, global nonprofit unit to provide 40 of the world’s poorest countries access to 30 essential medicines (PRESS RELEASE) PARIS, 7-Apr-2021 — … Read the full press release
Posted in France, Healthcare, News, Non Profit, Pharma & Biotech, Society
Tagged access to medicines, Cancer, cardiovascular disease, chronic diseases, climate change, Corporate Social Responsibility, CSR strategy, Diabetes, diversity, environmental protection program, Fabry, Gaucher, healthcare professionals, Inclusion, malaria, nonprofit unit, open letter, Paul Hudson, Pharmaceutical, Planet Mobilization, polio, Pompe diseases, preservation of the environment, rare diseases, Sanofi, Sanofi Global Health, sleeping sickness, support for vulnerable communities, tuberculosis, vaccines, WHO, World Health Organization, Zero plastic packaging
MUNICH, 14-Aug-2018 — /EuropaWire/ — Effective therapeutics to counteract the formation of amyloid plaques in Alzheimer’s disease and type 2 diabetes are not yet available. Scientists at the Technical University of Munich (TUM) have now come a little bit closer to … Read the full press release
STOCKHOLM, 18-Apr-2018 — /EuropaWire/ — One way that cancer may be fought in the future is with micro-sized capsules containing living cells engineered to secrete toxins that attack cancer cells. Although the science of cell micro-encapsulation has yet to overcome certain … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Sweden, Technology
Tagged Cancer, Diabetes, fight cancer, heart disease, heart_disease, implants, KTH, microparticles, Wouter van der Wijngaart
Leicestershire, UK, 17-Apr-2018 — /EuropaWire/ — The on-going debate over whether ‘health obesity’ exists is diverting attention away from effective medical research as academics continue to use the confusing classification. The concept – which relates to people with high BMI but … Read the full press release
Posted in Education, Healthcare, Science, Society, United Kingdom
Tagged biology, BMI, Diabetes, Dr Will Johnson, healthy, healthy obesity, hypertension, Loughborough University, Obesity
‘Smart’ CGM System Provides Predictive Alerts for Dangerous Sensor Glucose Levels; Exclusive Access to Sugar.IQ Assistant with Watson Offers More Proactive Diabetes Management DUBLIN, 13-Mar-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced it received … Read the full press release
Posted in Healthcare, Ireland, Pharma & Biotech
Tagged Annette Brüls, Diabetes, Dr. Timothy Bailey, glucose, Medtronic, predictive, US FDA
Medtronic Will Host an Exclusive Symposium on Thursday, February 15 VIENNA, 14-Feb-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its schedule of notable sessions that will be presented at the Advanced Technologies & Treatments for … Read the full press release
EXETER, 09-Feb-2018 — /EuropaWire/ — A world-leading diabetes expert today (Thursday 8th February) received his CBE for his work in revolutionising global diagnosis and treatment. Andrew Hattersley, Professor of Molecular Medicine at the University of Exeter and a diabetes consultant at the Royal Devon … Read the full press release
research also points to diabetes as cause of disease that can lead to limb amputation DUNDEE, 20-Sep-2017 — /EuropaWire/ — Smoking and diabetes are the two leading risk factors for peripheral artery disease (PAD), a narrowing of the arteries which can … Read the full press release
Posted in Education, Healthcare, Society, United Kingdom
Tagged Diabetes, peripheral artery disease, Professor Metin Avkiran, smoking, University of Dundee
iPro2 Professional CGM Provides Information to Help Physicians Optimize Care for Their Patients Regardless of Their Diabetes Therapy MILAN, 08-Feb-2016 — /EuropaWire/ — A retrospective analysis of the iPro2 Professional CGM from Medtronic plc (NYSE:MDT), the global leader in medical technology, … Read the full press release
For people suffering from diabetes, managing blood sugar can be like walking a tightrope – if too high they run the risk of serious long term complications such as blindness, kidney failure, limb gangrene and premature heart disease, but allow … Read the full press release
International team led by University of Leicester publish new findings Leicester, UK, 15-12-2014 — /EuropaWire/ — A study involving scientists from the University of Leicester has established a link between hypoglycaemia and increased risk of cardiovascular events and mortality in … Read the full press release
Initial focus on insulin-device combinations and care management services Paris and Minneapolis, Minn., 16-6-2014 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) and Medtronic, Inc. (NYSE: MDT) today announced that they have signed a memorandum of understanding to enter into a … Read the full press release
Posted in Business, France, Healthcare, Pharma & Biotech, Society
Tagged d Pascale Witz, Diabetes, Medtronic, Omar Ishrak, Sanofi
STEM CELLS A grant of 6 million euros for the HumEn project brings together leading European stem cell-research groups and industrial partners in a coordinated and collaborative effort aimed at developing glucose-responsive, insulin-producing beta cells for future cell-replacement therapy in diabetes. … Read the full press release
12-8-2013 — /EuropaWire/ — Research led by University of Leicester health expert aims to speed up impact for patients across the region Issued by Nottinghamshire Heathcare NHS Trust on 9 August 2013 A collaboration between the NHS and universities across the … Read the full press release
Posted in Education, Financial, Healthcare, Science, United Kingdom
Tagged asthma, Ather Mirza, Diabetes, East Midlands patients, mental health issues, NIHR CLAHRC East Midlands, Nottinghamshire Healthcare, Primary Care Diabetes, Professor Kamlesh Khunti, Professor Khunti, Professor Mike Cooke, University of Leicester health reseach, Vascular Medicine, £28.4M funding
2-7-2013 — /europawire.eu/ — New Phase III data presented at the American Diabetes Association 73rd Scientific Sessions® (ADA) showed linagliptin improved blood glucose control as monotherapy and in combination with metformin, in Asian people from China, Malaysia and the Philippines with … Read the full press release
Ingelheim, Germany and Indianapolis, US, 1-7-2013 — /europawire.eu/ — Boehringer Ingelheim and Eli Lilly and Company today announced results from a new analysis of Phase III data demonstrating that treatment with the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin is not associated with … Read the full press release
Posted in Business, Germany, Healthcare, Pharma & Biotech, Science
Tagged 73rd Scientific Sessions®, American Diabetes Association, Boehringer Ingelheim, Diabetes, dipeptidyl peptidase-4, DPP-4, Dr. Odd Erik Johansen, Eli Lilly, Germany, Indianapolis, Ingelheim, Linagliptin, T2D, type 2 diabetes, US
Leverkusen, 12-6-2013 — /europawire.eu/ — Bayer HealthCare supports local projects under the “Excellence across Borders” program in order to improve care of people with diabetes. Among the projects is a Diabetic School Awareness Program in the Kingdom of Saudi Arabia, which … Read the full press release
Posted in Education, Germany, Healthcare, Non Profit, Society
Tagged Bayer, Bayer HealthCare, Diabetes, diabetes management, diabetes projects, Diabetic School, Diabetic School Awareness Program, Dubai, Excellence across Borders, Gerd-Walter Rohm, Leverkusen, MONIKI, Moscow, Professor Dr. Alexander Dreval, Saudi Arabia, United Arab Emirates
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
